Bellevue Group’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,879,583
| Closed | -$47.8M | – | 163 |
|
|
2024
Q3 | $47.8M | Sell |
7,879,583
-10,000
| -0.1% | -$60.6K | 0.77% | 33 |
|
|
2024
Q2 | $41.5M | Hold |
7,889,583
| – | – | 0.67% | 39 |
|
|
2024
Q1 | $67M | Sell |
7,889,583
-9,000
| -0.1% | -$76.4K | 1.02% | 26 |
|
|
2023
Q4 | $52.1M | Hold |
7,898,583
| – | – | 0.8% | 37 |
|
|
2023
Q3 | $24.4M | Hold |
7,898,583
| – | – | 0.39% | 69 |
|
|
2023
Q2 | $21.3M | Hold |
7,898,583
| – | – | 0.3% | 76 |
|
|
2023
Q1 | $23.5M | Hold |
7,898,583
| – | – | 0.34% | 73 |
|
|
2022
Q4 | $19.9M | Buy |
7,898,583
+2,000,000
| +34% | +$5.04M | 0.26% | 84 |
|
|
2022
Q3 | $10.7M | Buy |
5,898,583
+888,869
| +18% | +$1.62M | 0.15% | 97 |
|
|
2022
Q2 | $15.8M | Sell |
5,009,714
-25,100
| -0.5% | -$79.1K | 0.22% | 94 |
|
|
2022
Q1 | $31.1M | Hold |
5,034,814
| – | – | 0.36% | 80 |
|
|
2021
Q4 | $71.5M | Hold |
5,034,814
| – | – | 0.74% | 48 |
|
|
2021
Q3 | $40.3M | Buy |
5,034,814
+2,575,000
| +105% | +$20.6M | 0.41% | 77 |
|
|
2021
Q2 | $70.3M | Buy |
2,459,814
+634,000
| +35% | +$18.1M | 0.69% | 50 |
|
|
2021
Q1 | $53M | Buy |
+1,825,814
| New | +$53M | 0.56% | 58 |
|